Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Krappmann

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|July 20, 2018
BCL10 - Bridging CARDs to Immune ActivationTorben Gehring, Thomas Seeholzer, Daniel Krappmann
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2015
In vitro detection of NEMO-ubiquitin binding using DELFIA and microscale thermophoresis assaysMichelle Vincendeau, Daniel Krappmann, Kamyar Hadian
Sub-Cellular Biochemistry|January 12, 2011
Ubiquitin Conjugation and Deconjugation in NF-κB SignalingMichael Düwel, Kamyar Hadian, Daniel Krappmann
Oncogene|April 13, 2004
Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activationMeike Broemer, Daniel Krappmann, Claus Scheidereit
Bio-Protocol|July 11, 2022
Optimized CRISPR-Cas9-based Strategy for Complex Gene Targeting in Murine Embryonic Stem Cells for Germline TransmissionThomas J O'Neill, Daniel Krappmann, Andreas Gewies
Molecular Immunology|February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activationAnnegret Bitzer, Michael Basler, Daniel Krappmann, et al.
Cancer Treatment Reviews|May 1, 2023
Function and targeting of MALT1 paracaspase in cancerThomas J O'Neill, Marie J Tofaute, Daniel Krappmann
Frontiers in Immunology|February 10, 2023
TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functionsThomas J O'Neill, Andreas Gewies, Thomas Seeholzer, et al.
Expert Opinion on Therapeutic Patents|April 10, 2025
An updated patent review of MALT1 inhibitors (2021-present)Matjaz Brvar, Thomas J O'Neill, Oliver Plettenburg, et al.
Expert Opinion on Therapeutic Patents|July 2, 2021
A patent review of MALT1 inhibitors (2013-present)Isabel Hamp, Thomas J O'Neill, Oliver Plettenburg, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|July 20, 2018
BCL10 - Bridging CARDs to Immune ActivationTorben Gehring, Thomas Seeholzer, Daniel Krappmann
Methods in Molecular Biology (Clifton, N.J.)|March 5, 2015
In vitro detection of NEMO-ubiquitin binding using DELFIA and microscale thermophoresis assaysMichelle Vincendeau, Daniel Krappmann, Kamyar Hadian
Sub-Cellular Biochemistry|January 12, 2011
Ubiquitin Conjugation and Deconjugation in NF-κB SignalingMichael Düwel, Kamyar Hadian, Daniel Krappmann
Oncogene|April 13, 2004
Requirement of Hsp90 activity for IkappaB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-kappaB activationMeike Broemer, Daniel Krappmann, Claus Scheidereit
Bio-Protocol|July 11, 2022
Optimized CRISPR-Cas9-based Strategy for Complex Gene Targeting in Murine Embryonic Stem Cells for Germline TransmissionThomas J O'Neill, Daniel Krappmann, Andreas Gewies
Molecular Immunology|February 4, 2017
Immunoproteasome subunit deficiency has no influence on the canonical pathway of NF-κB activationAnnegret Bitzer, Michael Basler, Daniel Krappmann, et al.
Cancer Treatment Reviews|May 1, 2023
Function and targeting of MALT1 paracaspase in cancerThomas J O'Neill, Marie J Tofaute, Daniel Krappmann
Frontiers in Immunology|February 10, 2023
TRAF6 controls T cell homeostasis by maintaining the equilibrium of MALT1 scaffolding and protease functionsThomas J O'Neill, Andreas Gewies, Thomas Seeholzer, et al.
Expert Opinion on Therapeutic Patents|April 10, 2025
An updated patent review of MALT1 inhibitors (2021-present)Matjaz Brvar, Thomas J O'Neill, Oliver Plettenburg, et al.
Expert Opinion on Therapeutic Patents|July 2, 2021
A patent review of MALT1 inhibitors (2013-present)Isabel Hamp, Thomas J O'Neill, Oliver Plettenburg, et al.
Pageof 10